Keim Mark Lowell 4
4 · MOLINA HEALTHCARE, INC. · Filed Feb 14, 2024
Insider Transaction Report
Form 4
Keim Mark Lowell
Chief Financial Officer
Transactions
- Sale
Common Stock
2024-02-12$385.80/sh−1,203$464,111→ 40,462 total - Sale
Common Stock
2024-02-12$388.61/sh−1,264$491,208→ 50,267 total - Sale
Common Stock
2024-02-12$387.94/sh−4,251$1,649,124→ 46,016 total - Sale
Common Stock
2024-02-12$387.00/sh−4,351$1,683,837→ 41,665 total - Sale
Common Stock
2024-02-12$384.58/sh−1,815$698,009→ 38,647 total - Sale
Common Stock
2024-02-12$383.82/sh−2,116$812,165→ 36,531 total
Footnotes (7)
- [F1]Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $388.430 to $388.805. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.
- [F2]Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $387.430 to $388.415. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.
- [F3]Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $386.43 to $387.37. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.
- [F4]Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $385.300 to $386.155. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.
- [F5]Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $384.19 to $385.17. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.
- [F6]Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $383.17 to $384.13. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.
- [F7]Amount of shares beneficially owned reflects an additional 102 shares arising from a calculation error in connection with the payment of withholding taxes related to a vesting event on January 10, 2020.